Literature DB >> 11525939

PI 3-K and T-cell activation: limitations of T-leukemic cell lines as signaling models.

E Astoul1, C Edmunds, D A Cantrell, S G Ward.   

Abstract

Phosphoinositide 3-kinases (PI 3-Ks) phosphorylate the d3-hydroxyl position of phosphatidylinositol (4,5)-bisphosphate [PtdIns(4,5)P(2)] resulting in the generation of the 3'-phosphoinositide lipid PtdIns(3,4,5)P(3). PI 3-Ks are activated by a diverse set of receptors that play a role in determining T-cell function. It now seems that leukemic T cells, which are widely used as models for T-cell biology, show constitutive activation of PI 3-K-mediated signal-transduction pathways. Hence, studies of the role of PI 3-K in T-cell biology using leukemic cell lines might have misinterpreted the importance of this pathway for T-cell signal transduction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11525939     DOI: 10.1016/s1471-4906(01)01973-1

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  37 in total

1.  T-cell antigen receptor signal transduction.

Authors:  Doreen A Cantrell
Journal:  Immunology       Date:  2002-04       Impact factor: 7.397

2.  Pleiotropic defects in TCR signaling in a Vav-1-null Jurkat T-cell line.

Authors:  Youjia Cao; Erin M Janssen; Andrew W Duncan; Amnon Altman; Daniel D Billadeau; Robert T Abraham
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

Review 3.  Regulation of immune cell development through soluble inositol-1,3,4,5-tetrakisphosphate.

Authors:  Karsten Sauer; Michael P Cooke
Journal:  Nat Rev Immunol       Date:  2010-04       Impact factor: 53.106

4.  Akt2 inhibits the activation of NFAT in lymphocytes by modulating calcium release from intracellular stores.

Authors:  Victoria A Martin; Wen-Horng Wang; Andrew M Lipchik; Laurie L Parker; Yantao He; Sheng Zhang; Zhong-Yin Zhang; Robert L Geahlen
Journal:  Cell Signal       Date:  2012-01-11       Impact factor: 4.315

Review 5.  Integrative biology of T cell activation.

Authors:  Bernard Malissen; Claude Grégoire; Marie Malissen; Romain Roncagalli
Journal:  Nat Immunol       Date:  2014-09       Impact factor: 25.606

6.  Differential regulation of the IL-17 receptor by gammac cytokines: inhibitory signaling by the phosphatidylinositol 3-kinase pathway.

Authors:  Matthew J Lindemann; Zihua Hu; Marta Benczik; Kathleen D Liu; Sarah L Gaffen
Journal:  J Biol Chem       Date:  2008-03-17       Impact factor: 5.157

7.  T-cell receptor early signalling complex activation in response to interferon-alpha receptor stimulation.

Authors:  Claire N Stevens; Ann-Marie Simeone; Susan John; Zamal Ahmed; Orso M Lucherini; C Tatiana Baldari; John E Ladbury
Journal:  Biochem J       Date:  2010-05-27       Impact factor: 3.857

8.  Apoptotic signaling activated by modulation of the F0F1-ATPase: implications for selective killing of autoimmune lymphocytes.

Authors:  Thomas B Sundberg; Lara Swenson; Daniel R Wahl; Anthony W Opipari; Gary D Glick
Journal:  J Pharmacol Exp Ther       Date:  2009-08-25       Impact factor: 4.030

Review 9.  PIP3 pathway in regulatory T cells and autoimmunity.

Authors:  Masaki Kashiwada; Ping Lu; Paul B Rothman
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

10.  Tumor-shed PGE(2) impairs IL2Rgammac-signaling to inhibit CD4 T cell survival: regulation by theaflavins.

Authors:  Sreya Chattopadhyay; Sankar Bhattacharyya; Baisakhi Saha; Juni Chakraborty; Suchismita Mohanty; Dewan Md Sakib Hossain; Shuvomoy Banerjee; Kaushik Das; Gaurisankar Sa; Tanya Das
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.